New achalasia study findings recently were reported by researchers at University of Wisconsin

Researchers detail in 'A controversy that has been tough to swallow: is the treatment of achalasia now digested,' new data in achalasia. According to a study from the United States, "Esophageal achalasia is a rare neurodegenerative disease of the esophagus and the lower esophageal sphincter that presents within a spectrum of disease severity related to progressive pathological changes, most commonly resulting in dysphagia. The pathophysiology of achalasia is still incompletely understood, but recent evidence suggests that degeneration of the postganglionic inhibitory nerves of the myenteric plexus could be due to an infectious or autoimmune mechanism, and nitric oxide is the...

Want to see the full article?

• Purchase this article for only $3.00